-
Priporočila Slovenskega združenja za gastroenterologijo in hepatologijo za zdravljenje okužbe z bakterijo Helicobacter pylori = Slovenian society for gastroenterology and hepatology guidelines on the management of Helicobacter pylori infectionTepeš, Bojan ; Štabuc, BorutInfection with Helicobacter pylori (Hp) is the most common infecion in the world. Half of the world population is infected. The prevalence of infection is declining in the developed world and also in ... Slovenia, because of better sanitation and eradication therapies. The prevalence of infection with Hp in Slovenia is 25.1%. Only 20% of the infected will develop a duodenal or gastriculcer, ALT lymphoma or cancer in their lifetime. Hp infection is a riskfactor for ulcer bleeding in patients on nonsteroidal antiinflammatory drugs and salicylates. Gastoenterologists diagnose the infection with Hp and prescribe therapy. A general practitioner can diagnose the infection by urea breath test or Hp stool test and prescribe therapy in cases of patients with aproven ulcer disease or in patients with first- degree relatives with gastriccancer. The guidelines on the management of Hp infection, published by the Slovenian Society for Gastroenterology and Hepatology (SZGH) in 2010, recommend one week therapy with proton pump inhibitor (PPI) bid, clarithromycin 500 mg bid and amoxiclline 1000 mg bid in patients without prior therapy with clarithromycin. In the case of prior therapy with macrolides, clarithromycin must be changed for metronidazole 400 mg bid. In the case of therapeutic failure second-line therapy should last 10 days. Secondline therapy can be based on Hp culture and bacterial resistance. The other possibility is PPI bid, colloidal bismuth subcitrate 120 mg qid, oxytetracycline 250 mg qid, metronidazole 400 mg qid; sequential therapy: PI bid 10 days, amoxicillin 1000 mg bid for first 5 days, clarithromycin 500 mg bid and metronidazole 400 mg bid for second 5 days; or PPI bid, amoxicilline 1000 mg bid and levofloxacin 500 mg bid. Hp is a group I human carcinogen responsible for 65% of all gastric cancers. (Abstract truncated at 2000 characters)Vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 80, št. 9, sep. 2011, str. 647-656)Vrsta gradiva - članek, sestavni delLeto - 2011Jezik - slovenskiCOBISS.SI-ID - 28952281
Avtor
Tepeš, Bojan |
Štabuc, Borut
Teme
Helicobacter Pylori |
Helicobacter Infections |
Congenital |
Drug Therapy |
Gastritis |
Peptic Ulcer |
Stomach Neoplasms |
Lymphoma, Mucosa-Associated Lymphoid Tissue |
Gastroesophageal Reflux |
Anemia |
Gastroenterology |
Practice Guidelines |
Gastritis |
Peptični ulkus |
Helicobacter, infekcije |
Želodec, novotvorbe |
Helicobacter pylori |
Anemija |
Praktična navodila |
Gastroenterologija |
Gastroezofagealni refluks |
Limfom mieloidnega tkiva, povezani z sluznico
vir: Zdravniški vestnik : glasilo Slovenskega zdravniškega društva = Slovenian medical journal = journal of Slovenian Medical Association. - ISSN 1318-0347 (Letn. 80, št. 9, sep. 2011, str. 647-656)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Tepeš, Bojan | 07942 |
Štabuc, Borut | 11949 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi